Literature DB >> 3926822

Prostacyclin production by the deendothelialized rabbit aorta.

J M Boeynaems, N Galand, P Ketelbant.   

Abstract

The acute effect of in vitro deendothelialization on the production of prostacyclin (PGI2) by the rabbit aorta has been investigated. The effectiveness of removing endothelium by rubbing it against filter paper or scraping it with a scalpel was demonstrated by scanning electron microscopy and en face examination after silver staining. Endothelium removal produced an immediate stimulation of PGI2 release, resulting in 408% of the control after rubbing and 367% of the control after scraping, during the first 30-min period of incubation. This increased production of PGI2 gradually declined over time to reach values similar to the control after 2h. At that time, the deendothelialized aorta was totally unresponsive to the stimuli that increase PGI2 release in the intact aorta (acetylcholine, ADP, ionophore A23187, and arachidonic acid). The enhanced production of PGI2 in the deendothelialized aorta was associated with an increased release of free arachidonic acid (353% of the control): in contrast with PGI2, this stimulation was maintained for at least 150 min. A transient exposure of the deendothelialized aorta to ibuprofen (250 microM) was followed by a rebound of PGI2 production, which was also prolonged by BW-755C (3-10 microM). In conclusion, removal of the endothelium triggered an immediate and sustained mobilization of free arachidonic acid in the rabbit aorta: the resulting increase of PGI2 production was short-lived, probably as a consequence of cyclooxygenase self-inactivation. Our results indicate that the subendothelium has a significant capacity to produce PGI2, but that this capacity is expressed only briefly.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926822      PMCID: PMC423693          DOI: 10.1172/JCI111979

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Cellular pathology of the rat aorta. Pseudo-vacuoles and myo-endothelial herniae.

Authors:  E M Stetz; G Majno; I Joris
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-31

2.  Some investigations into the role of prostacyclin in thromboregulation.

Authors:  G Hornstra; E Haddeman; J A Don
Journal:  Thromb Res       Date:  1978-02       Impact factor: 3.944

3.  Localisation and stimulation of prostacyclin production in vascular cells.

Authors:  D E MacIntyre; J D Pearson; J L Gordon
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

4.  Detection of prostaglandin F2 alpha as pentafluorobenzyl ester by electron-capture GLC.

Authors:  J A Wickramasinghe; W Morozowich; W E Hamlin; S R Shaw
Journal:  J Pharm Sci       Date:  1973-09       Impact factor: 3.534

5.  Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture.

Authors:  J H Chamley; G R Campbell; J D McConnell; U Gröschel-Stewart
Journal:  Cell Tissue Res       Date:  1977-02-14       Impact factor: 5.249

6.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

7.  Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells.

Authors:  A Eldor; D J Falcone; D P Hajjar; C R Minick; B B Weksler
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Endothelium modifies the altered metabolism of the injured aortic wall.

Authors:  D P Hajjar; D J Falcone; S Fowler; C R Minick
Journal:  Am J Pathol       Date:  1981-01       Impact factor: 4.307

9.  Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta.

Authors:  J Larrue; M Rigaud; D Daret; J Demond; J Durand; H Bricaud
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

10.  Aspirin: an unexpected side effect on prostacyclin synthesis in cultured vascular smooth muscle cells.

Authors:  J Whiting; K Salata; J M Bailey
Journal:  Science       Date:  1980-11-07       Impact factor: 47.728

View more
  8 in total

1.  Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.

Authors:  H Bitterman; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

2.  Enhancement of the endothelial production of prostacyclin by inhibitors of protein synthesis.

Authors:  J M Boeynaems; O Boutherin-Falson; C Lagneau; N Galand
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

3.  Role of vascular adrenergic mechanisms in the haemodynamic and PGI2 stimulating effects of angiotensin in diabetic dogs.

Authors:  M Z Koltai; I Pósa; E Kocsis; P Rösen; G Pogátsa
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

4.  Effects of polycations on pulmonary vascular permeability in conscious sheep.

Authors:  T Toyofuku; S Koyama; T Kobayashi; S Kusama; G Ueda
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Effects of amiloride analogues on the production of prostacyclin by aortic endothelial cells.

Authors:  J M Boeynaems; D Demolle; C Lagneau; E J Cragoe
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

6.  Inhibitory effect of clentiazem (TA-3090), a new calcium antagonist, on balloon catheter-induced intimal thickening of rabbit aorta.

Authors:  Y Saso; A Ohtani; A Odawara; H Iwasaki; K Takashima; T Morita
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

7.  Influence of atherosclerosis on vascular responsiveness in isolated rabbit vascular smooth muscle.

Authors:  A M Lefer; J A Osborne; A Yanagisawa; J Z Sun
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

8.  Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries.

Authors:  M Z Koltai; P Rösen; P Hadházy; G Ballagi-Pordány; A Köszeghy; G Pogátsa
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.